D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea flag South Korea · Delayed Price · Currency is KRW
95,900
-700 (-0.72%)
At close: Dec 5, 2025

D&D Pharmatech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
4,164,484513,608----
Upgrade
Enterprise Value
4,132,651494,061----
Upgrade
Last Close Price
95900.0012150.00----
Upgrade
PS Ratio
497.9744.91----
Upgrade
PB Ratio
55.627.38----
Upgrade
P/TBV Ratio
92.8714.45----
Upgrade
EV/Sales Ratio
-43.20----
Upgrade
Debt / Equity Ratio
0.090.140.151.470.320.03
Upgrade
Asset Turnover
0.090.130.220.000.01-
Upgrade
Quick Ratio
8.743.202.280.471.146.63
Upgrade
Current Ratio
9.823.582.610.611.227.28
Upgrade
Return on Equity (ROE)
-47.71%-47.25%9.29%-174.72%-43.71%-38.23%
Upgrade
Return on Assets (ROA)
-19.54%-17.70%-9.75%-24.89%-19.70%-16.52%
Upgrade
Return on Capital (ROIC)
-22.98%-21.91%-15.45%-37.70%-25.64%-25.07%
Upgrade
Return on Capital Employed (ROCE)
-34.40%-29.00%-18.80%-177.30%-41.10%-31.40%
Upgrade
Earnings Yield
-0.83%-5.57%----
Upgrade
FCF Yield
-0.59%-4.32%----
Upgrade
Buyback Yield / Dilution
-144.63%-8.08%-16.38%2.05%-12.66%-118.38%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.